Ownership Form of Derivative Security: Direct (D) or Indirect (I)ġ1. Number of derivative Securities Beneficially Owned Following Reported Transaction(s)ġ0.

Title and Amount of Securities Underlying Derivative Securityĩ. Number of Derivative Securities Acquired (A) or Disposed of (D)ħ. Deemed Execution Date, if any (Month/Day/Year)ĥ. Conversion or Exercise Price of Derivative SecurityģA. ( e.g., puts, calls, warrants, options, convertible securities)Ģ. Table II - Derivative Securities Beneficially Owned ( e.g., puts, calls, warrants, options, convertible securities) Ownership Form: Direct (D) or Indirect (I)ħ. Amount of Securities Beneficially Owned Following Reported Transaction(s)Ħ. Securities Acquired (A) or Disposed of (D)ĥ. Deemed Execution Date, if any (Month/Day/Year)Ĥ. Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially OwnedĢA. _ Form filed by More than One Reporting Person Individual or Join/Group Filing(Check Applicable Line) If Amendment, Date Original Filed(Month/Day/Year)Ħ. Date of Earliest Transaction (Month/Day/Year)Ĥ. Relationship of Reporting Person(s) to IssuerĬ/O RAPT THERAPEUTICS, INC.,, 561 ECCLES AVENUEģ.

Issuer Name and Ticker or Trading Symbolĥ. OMB Number:3235-0287Expires:January 31, 2005Estimated average burden hours per response.0.5ġ. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Check this box if no longer subject to Section 16, Form 4 or Form 5 obligations may continue.

Rapt stock price